prostate-cancer-calculator
Clinical decision support for prostate cancer: risk stratification (NCCN/EAU/CAPRA), LNI prediction (Briganti/Roach), PSADT/BCR assessment, salvage RT planning, and Polish NFZ drug programmes (B.56 for apalutamide/darolutamide/enzalutamide/olaparib/niraparib/talazoparib, C.87 for abiraterone). Covers mHSPC, nmCRPC, mCRPC eligibility, qualification criteria, dosing, and monitoring.
Installation and usage
Clinical decision support for prostate cancer: risk stratification (NCCN/EAU/CAPRA), LNI prediction (Briganti/Roach), PSADT/BCR assessment, salvage RT planning, and Polish NFZ drug programmes (B.56 for apalutamide/darolutamide/enzalutamide/olaparib/niraparib/talazoparib, C.87 for abiraterone). Covers mHSPC, nmCRPC, mCRPC eligibility, qualification criteria, dosing, and monitoring.
安裝後，您可以通過在終端運行以下命令來使用此技能：
skills use prostate-cancer-calculator